Abstract - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
Ambulatory Inotrope Infusions in Advanced Heart Failure - A Systematic Review and Meta-Analysis
Heart failure with preserved ejection fraction: from mechanisms to therapies
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions
The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper
Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation: A Cohort Study
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

|<<... 109 110 111 112 113 114 115 ...>>|

Clinical Trial

Nov. 17, 2019

JOURNAL：Circulation.

Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial

MN Kosiborod, PJhund, KF Docherty et al.

3220

Keywords: dapagliflozin; HFrEF; quality of life; cardiovascular outcomes

FULL TEXT PDF